Application Sponsors
ANDA 214420 | ASCENT PHARMS INC | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Application Products
001 | TABLET, EXTENDED RELEASE;ORAL | 5MEQ | 0 | POTASSIUM CITRATE | POTASSIUM CITRATE |
002 | TABLET, EXTENDED RELEASE;ORAL | 10MEQ | 0 | POTASSIUM CITRATE | POTASSIUM CITRATE |
003 | TABLET, EXTENDED RELEASE;ORAL | 15MEQ | 0 | POTASSIUM CITRATE | POTASSIUM CITRATE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2021-02-05 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
003 | Prescription | AB |
CDER Filings
ASCENT PHARMS INC
cder:Array
(
[0] => Array
(
[ApplNo] => 214420
[companyName] => ASCENT PHARMS INC
[docInserts] => ["",""]
[products] => [{"drugName":"POTASSIUM CITRATE","activeIngredients":"POTASSIUM CITRATE","strength":"5MEQ","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"POTASSIUM CITRATE","activeIngredients":"POTASSIUM CITRATE","strength":"10MEQ","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"POTASSIUM CITRATE","activeIngredients":"POTASSIUM CITRATE","strength":"15MEQ","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"02\/05\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2021-02-05
)
)